SONOGRAPHIC EVALUATION OF UTERUS IN POST MENUPAUSAL WOMEN SUFFERING WITH DIABETES
DOI:
https://doi.org/10.71000/aasjkq11Keywords:
Diabetes Mellitus, Endometrial Thickening, Menopause, Postmenopausal Women, Sonography, , Uterine Fibroids, UterusAbstract
Background: Menopause represents the natural cessation of menstruation and the end of a woman’s reproductive phase, typically occurring between 45 and 55 years of age. This transition is marked by hormonal fluctuations, primarily the decline in estrogen levels, which may predispose women to various systemic and gynecological changes. Diabetes mellitus (DM), particularly Type 2 diabetes, is an escalating global health concern that further complicates postmenopausal health by influencing uterine structure and endometrial morphology through metabolic and vascular mechanisms.
Objective: This study aimed to evaluate the uterine morphology and endometrial characteristics in postmenopausal women with diabetes using sonographic assessment and to determine the association between diabetes and gynecological complications.
Methods: A cross-sectional observational study was conducted in the Department of Radiology, Sir Ganga Ram Hospital, Lahore, over five months. A total of 86 postmenopausal women aged 45–65 years diagnosed with diabetes mellitus were enrolled through convenient sampling. Data were collected using a structured, self-designed questionnaire documenting demographic characteristics, medical history, menopausal age, and diabetic profile. All participants underwent standardized gray-scale and Doppler sonography using a Toshiba Aloka Prosound SSD-3500SX machine with 3.5 MHz curvilinear and 7.5 MHz linear probes to assess uterine size, morphology, and endometrial thickness.
Results: Among 86 participants, Type 2 diabetes was slightly more prevalent (51.2%) than Type 1 (48.8%). The majority (54.7%) experienced menopause between 40–45 years, and 84.9% reported postmenopausal gynecological symptoms. Sonographic findings revealed endometrial thickening in 39.5%, uterine fibroids in 40.7%, and uterine cancer in 14%. Statistical analysis showed a significant association between diabetes and gynecological complications (χ² = 32.605, p < 0.001), but no significant relationship between diabetes duration and complication occurrence (p = 0.607).
Conclusion: The study concluded that while diabetes is associated with a higher frequency of uterine abnormalities, the duration of diabetes did not significantly influence gynecological complications. Other factors such as obesity, hormonal imbalance, and metabolic changes may contribute more prominently to uterine pathology in postmenopausal women. Regular sonographic screening is recommended for early detection and prevention of complications.
References
Dashti SG, English DR, Simpson JA, Karahalios A, Moreno-Betancur M, Biessy C, et al. Adiposity and Endometrial Cancer Risk in Postmenopausal Women: A Sequential Causal Mediation Analysis. Cancer Epidemiol Biomarkers Prev. 2021;30(1):104-13.
Erdemoglu E, Serel TA, Karacan E, Köksal OK, Turan İ, Öztürk V, et al. Artificial intelligence for prediction of endometrial intraepithelial neoplasia and endometrial cancer risks in pre- and postmenopausal women. AJOG Glob Rep. 2023;3(1):100154.
Michalczyk K, Kapczuk P, Witczak G, Bosiacki M, Kurzawski M, Chlubek D, et al. The Associations between Metalloestrogens, GSTP1, and SLC11A2 Polymorphism and the Risk of Endometrial Cancer. Nutrients. 2022;14(15).
Fonseca-Velázquez SJ, López-Martínez R, Sosa-Bustamante GP, González AP, Paque-Bautista C, Luna-Anguiano JLF, et al. [Body mass index and triponderal index in abnormal uterine bleed]. Rev Med Inst Mex Seguro Soc. 2023;61(Suppl 2):S135-s40.
Brewster LM, Haan Y, van Montfrans GA. Cardiometabolic Risk and Cardiovascular Disease in Young Women With Uterine Fibroids. Cureus. 2022;14(10):e30740.
Simon MS, Hastert TA, Barac A, Banack HR, Caan BJ, Chlebowski RT, et al. Cardiometabolic risk factors and survival after cancer in the Women's Health Initiative. Cancer. 2021;127(4):598-608.
Fujito H, Yasui T, Awazu Y, Tanaka K, Oue K, Wada T, et al. A Case of Postmenopausal Uterine Adenosarcoma With Concomitant Diabetes Mellitus. Cureus. 2025;17(2):e78978.
Patrizi L, Ticconi C, Borelli B, Finocchiaro S, Chiaramonte C, Sesti F, et al. Clinical significance of endometrial abnormalities: an observational study on 1020 women undergoing hysteroscopic surgery. BMC Womens Health. 2022;22(1):106.
Li X, Wang H, Wang T, Cui H, Wu L, Wang W, et al. Combining demographic data and transvaginal ultrasonography: a predictive model for endometrial carcinoma in postmenopausal patients. BMC Womens Health. 2024;24(1):539.
Mitro SD, Waetjen LE, Lee C, Wise LA, Zaritsky E, Harlow SD, et al. Diabetes and Uterine Fibroid Diagnosis in Midlife: Study of Women's Health Across the Nation (SWAN). J Clin Endocrinol Metab. 2025;110(6):e1934-e42.
Yang X, Li X, Dong Y, Fan Y, Cheng Y, Zhai L, et al. Effects of Metabolic Syndrome and Its Components on the Prognosis of Endometrial Cancer. Front Endocrinol (Lausanne). 2021;12:780769.
Petersdorf K, Groettrup-Wolfers E, Overton PM, Seitz C, Schulze-Rath R. Endometrial hyperplasia in pre-menopausal women: A systematic review of incidence, prevalence, and risk factors. Eur J Obstet Gynecol Reprod Biol. 2022;271:158-71.
[Expert consensus on the diagnosis and treatment of obstructive sleep apnea in women]. Zhonghua Jie He He Hu Xi Za Zhi. 2024;47(6):509-28.
Ruth KS, Day FR, Hussain J, Martínez-Marchal A, Aiken CE, Azad A, et al. Genetic insights into biological mechanisms governing human ovarian ageing. Nature. 2021;596(7872):393-7.
Lin F, Ma L, Sheng Z. Health disorders in menopausal women: microbiome alterations, associated problems, and possible treatments. Biomed Eng Online. 2025;24(1):84.
Helvaci N, Yildiz BO. The impact of ageing and menopause in women with polycystic ovary syndrome. Clin Endocrinol (Oxf). 2022;97(3):371-82.
Hruda M, Robová H, Sehnal B, Babková A, Pichlík T, Drozenová J, et al. Malignant transformation of extragenital endometriosis. Ceska Gynekol. 2024;89(6):486-92.
Kase NG, Gretz Friedman E, Brodman M, Kang C, Gallagher EJ, LeRoith D. The midlife transition and the risk of cardiovascular disease and cancer Part I: magnitude and mechanisms. Am J Obstet Gynecol. 2020;223(6):820-33.
Çaltek N, Çaltek H, Yassa M, Güner G, Yaman İ, Yüksel İ T. Preoperative predictors of endometrial carcinoma in patients undergoing hysterectomy for endometrial intraepithelial neoplasia. BMC Cancer. 2025;25(1):883.
Wang L, Wei W, Cai M. A Review of the Risk Factors Associated with Endometrial Hyperplasia During Perimenopause. Int J Womens Health. 2024;16:1475-82.
Ryu KJ, Kim MS, Lee JY, Nam S, Jeong HG, Kim T, et al. Risk of Endometrial Polyps, Hyperplasia, Carcinoma, and Uterine Cancer After Tamoxifen Treatment in Premenopausal Women With Breast Cancer. JAMA Netw Open. 2022;5(11):e2243951.
Li Z, Yin J, Liu Y, Zeng F. A risk prediction model for endometrial hyperplasia/endometrial carcinoma in premenopausal women. Sci Rep. 2025;15(1):1019.
Shen Y, Li L, Wang H, Hu Y, Deng X, Lian X, et al. Triage method for endometrial biopsy in postmenopausal women: a multicenter retrospective cohort study. Menopause. 2023;30(12):1206-12.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Hafiza Hijab Rehman, Hafiza Maria Fawad , Eman Shahzadi , Muqadas Arif , Zahid Mahmood, Arshia Majid, Zafar Iqbal (Author)

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.





